Use stem cells, get sued

Dimitri Bonnville got cardiac stem cell therapy. Now he's suing

Written byAdam Marcus
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

When Dimitri Bonnville of Almont, Michigan, was shot in the chest with a nail gun by a construction coworker two years ago, the then 16-year-old eventually wound up at William Beaumont Hospital in Royal Oak, where James Robbins, a trauma surgeon, removed the three-inch-long spike from his right ventricle.

The procedure worked-at first. But the teenager soon suffered a major heart attack, prompting Beaumont physicians to suggest a radical-and, some say, unwarranted-step: They offered the boy an experimental stem cell transplant to rejuvenate his dead myocardium. Bonnville and his parents agreed, and he soon became the first cardiac stem cell recipient in the United States-a feat William Beaumont trumpeted in press releases that featured Bonnville and his family as willing participants.

Evidently, they've had a change of, er, heart. Earlier this year, the Bonnvilles filed suit against William Beaumont Hospital, Robbins, and Srinivas Dukkipati, the cardiology fellow who saw Bonnville ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies